Clearwater International advises PHMR on its sale to Ashfield Advisory
Clearwater International has advised PHMR Ltd, a global consultancy specialising in market access and health economics outcomes research (HEOR) on its sale to Ashfield Advisory, part of UDG Healthcare Plc, an ecosystem of connected advisory and consultancy businesses for the life sciences industry.
Founded in 2008, PHMR is headquartered in London with offices in Newcastle, UK and Westport, Ireland.
The business employs 40 multidisciplinary, highly-qualified team members of health economists and research scientists, and specialises in health economics, real world evidence, patient reported outcomes, health technology assessment and other HEOR activities, which support market access for a global biopharmaceutical clients.
As part of the sale, PHMR will join the existing Ashfield Advisory company, Putnam Associates, which specialises in strategy consulting exclusively for the biopharmaceutical and medical device industry.
The Clearwater International team consisted of Partner Carl Houghton, Director Hemavli Bali, Associate Directors Will Arnold and Kirsty Handley and Associate Gregory Cornes.
Mark Ratcliffe, Founder, PHMR Ltd said: “This acquisition brings great opportunities to both our current and future clients, as we’ll be able to offer the same exceptional service, with the added value of being connected to the Ashfield Advisory ecosystem, as and when our clients need additional support. I am extremely proud of the team at PHMR and what we have achieved together. I am very grateful for all their hard work, and I am looking forward to seeing what we can accomplish together as part of the Ashfield Advisory team.”